These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Barriere SL; Guglielmo BJ Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812 [TBL] [Abstract][Full Text] [Related]
3. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis. Smith CR; Straube RC; Ziegler EJ Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120 [TBL] [Abstract][Full Text] [Related]
4. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630 [No Abstract] [Full Text] [Related]
5. Another negative clinical trial of a new agent for the treatment of sepsis: rethinking the process of developing adjuvant treatments for serious infections. Fink MP Crit Care Med; 1995 Jun; 23(6):989-91. PubMed ID: 7774236 [No Abstract] [Full Text] [Related]
7. Human monoclonal antibodies in sepsis. de Koning J; Westendorp RG Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215 [No Abstract] [Full Text] [Related]
8. Antibody to endotoxin in the treatment of gram-negative sepsis. Schentag JJ JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766 [No Abstract] [Full Text] [Related]
9. Antibody to endotoxin in the treatment of gram-negative sepsis. Spalter J JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764 [No Abstract] [Full Text] [Related]
10. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels. Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255 [TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy using the anti-endotoxin antibody HA-1A (Centoxin) in patients with sepsis syndrome; fair results following protocol selection of patients]. Costongs LG; Speelman P; van Lieshout JJ; van Deventer SJ; Lubbers MJ; Schipper HG Ned Tijdschr Geneeskd; 1993 Feb; 137(7):355-60. PubMed ID: 8437634 [TBL] [Abstract][Full Text] [Related]
12. Role of immunomodulator therapy in sepsis. Caplan ES Am J Surg; 1993 Feb; 165(2A Suppl):20S-25S. PubMed ID: 8438996 [TBL] [Abstract][Full Text] [Related]
13. Antibody to endotoxin in the treatment of gram-negative sepsis. McCabe WR JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763 [No Abstract] [Full Text] [Related]
14. Antibody to endotoxin in the treatment of gram-negative sepsis. van Deventer S JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765 [No Abstract] [Full Text] [Related]
15. [Immunotherapy using the anti-endotoxin antibody HA-1A in patients with sepsis syndrome; good results in relation to treatment with placebo]. Wortel CH; von der Möhlen MA; van Deventer SJ; Schipper HG; Lorijn RH; ten Cate JW Ned Tijdschr Geneeskd; 1993 Feb; 137(7):350-4. PubMed ID: 8437633 [TBL] [Abstract][Full Text] [Related]